share_log

Canaccord Genuity Maintains Hold on Staar Surgical, Lowers Price Target to $43

Canaccord Genuity Maintains Hold on Staar Surgical, Lowers Price Target to $43

Canaccord Genuity 繼續持有 Staar Surgical,將目標股價下調至43美元
Benzinga ·  05/08 13:00

Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $46 to $43.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論